Therapeutics: Neurofibromin 1 (NF1)

Cancer

INDICATION: Neurofibromatosis

Mouse studies suggest MEK inhibitors could help treat neurofibromatosis type 1,

Read the full 134 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE